Transcranial Direct Current Stimulation Safe, Effective for Tardive Dyskinesia
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with schizophrenia, according to a study published online in the October issue of Clinical Neurophysiology.
Xiaoli Lyu, from the Teaching Hospital of Yangzhou University in China, and colleagues evaluated the efficacy and safety of tDCS in long-term hospitalized patients with chronic schizophrenia and TD. The analysis included 64 patients randomly assigned to active (35 participants) or sham (29 participants) treatment (15 30-minute sessions).
The researchers found that patients in the active group showed a significant reduction in both the total Abnormal Involuntary Movements Scale (AIMS) score and the facial-oral subscore. In the active group, a significant AIMS total score improvement of ≥30 percent was achieved in half of patients versus 8.3 percent in the sham group. The Positive and Negative Syndrome Scale and the Scale for the Assessment of Negative Symptoms scores did not significantly differ between the treatment groups. The occurrence of the reported adverse effect of tingling sensation differed significantly between the groups.
"The results of our study are expected to provide a novel perspective for the treatment of patients with chronic schizophrenia complicated by TD in clinical settings," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-19 12:00
Read more
- Electronic Sepsis Screening Reduces 90-Day In-Hospital Mortality
- Early Adoption of Tobacco 21 Policies Can Avert Premature Mortality
- AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
- Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
- Cognitive Behavioral Therapy Aids Patients With Long COVID
- Premature Birth Could Impact Life Span for Decades
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions